Actos Litigation Status Hearing Looming

Actos litigation is well underway.  Tomorrow, December 13, 2012, marks the next status hearing regarding the multi-district litigation case, In re: Actos (Pioglitazone) Products Liability Litigation - MDL No. 2299.  As the Actos litigation heats up, patients are still coming forward with claims that they developed bladder cancer, potentially after taking their prescription medication, Actos.

What are the Actos lawsuits about?

The Actos litigation centers on patient claims that the manufacturer, Takeda Pharmaceuticals, and other defendants concealed information that taking Actos could cause bladder cancer.  Patients allege that they were not adequately warned about the potential for bladder cancer, and have become ill as a result. 

Actos was originally intended to be the answer to Avandia, a predecessor which was often linked to heart problems.  Yet if this information is true, both of these type 2 diabetes drugs sound like they were bad choices.  They were intended to control the body's sensitivity to insulin that happens with type 2 diabetes' insulin resistance.  Doctors usually prescribed this drug in conjunction with dietary changes and regular exercise.  Yet, scientific studies have emerged which strongly suggest that Actos is linked to bladder cancer.  And the FDA released a health warning that taking Actos for a year or longer could cause a 40% increase in risk for bladder cancer. 

Have you been injured by Actos?

Patients across the United States have filed suit against Takeda Pharmaceuticals and other defendants, claiming Actos caused bladder cancer.  If you have similarly developed bladder cancer which you suspect may be due to your usage of Actos, you may want to discuss your legal options with a skilled product liability attorney.  You may be entitled to compensation for these injuries.  Don't mess with your health.  Obtain the relief you need.